ACER THERAPEUTICS INC.

Profile

Company Names

ACER THERAPEUTICS INC.
OPEXA THERAPEUTICS, INC.

Addresses

ONE GATEWAY CENTER, SUITE 356, 300 WASHINGTON STREET, NEWTON, MA 02458

ONE GATEWAY CENTER, SUITE 351, 300 WASHINGTON STREET, NEWTON, MA 02458

2635 TECHNOLOGY FOREST BLVD., THE WOODLANDS, TX 77381

2635 N. CRESCENT RIDGE DRIVE, THE WOODLANDS, TX 77381

Phone Numbers

(844) 902-6100
(281) 272-9331

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

TX

Total Amount Raised:

$8,193,492.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-11-29 
$1,499,999.00 
$1,499,999.00 
$0.00 
Equity 
5
2020-07-24 
$857,493.00 
$857,493.00 
$0.00 
Equity 
4
2013-01-29 
$0.00 
INDEFINITE 
INDEFINITE 
 
3
2013-01-23 
$650,000.00 
$650,000.00 
$0.00 
Debt 
2
2012-07-25 
$4,085,000.00 
$4,085,000.00 
$0.00 
Debt 
1
2009-04-14 
$1,101,000.00 
$2,000,000.00 
$899,000.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JASON 
 
AMELLO 
DIRECTOR
STEPHEN 
 
ASELAGE 
DIRECTOR
JEFFERSON 
E. 
DAVIS 
EXECUTIVE OFFICER
JOHN 
DUNN 
DIRECTOR
MICHELLE 
 
GRIFFIN 
DIRECTOR
TANYA 
 
HAYDEN 
EXECUTIVE OFFICER
DAVID 
E. 
JORDEN 
DIRECTOR, EXECUTIVE OFFICER
DONALD 
JOSEPH 
EXECUTIVE OFFICER
DONALD 
R. 
JOSEPH 
EXECUTIVE OFFICER
JOHN 
M. 
KLOPP 
EXECUTIVE OFFICER
GAIL 
J. 
MADERIS 
DIRECTOR
DAVID 
B. 
MCWILLIAMS 
DIRECTOR
HARRY 
PALMIN 
EXECUTIVE OFFICER
HARRY 
S. 
PALMIN 
EXECUTIVE OFFICER
BERNIE 
 
PAUL 
EXECUTIVE OFFICER
ADRIAN 
 
QUARTEL 
EXECUTIVE OFFICER
MICHAEL 
S. 
RICHMAN 
DIRECTOR
DONNA 
R. 
RILL 
EXECUTIVE OFFICER
CHRIS 
 
SCHELLING 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
B. 
SEAMAN 
DIRECTOR
MATTHEW 
 
SEIBT 
EXECUTIVE OFFICER
MATTHEW 
T. 
SEIBT 
EXECUTIVE OFFICER
JAYE 
L. 
THOMPSON 
EXECUTIVE OFFICER
NEIL 
K. 
WARMA 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-11-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-24 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2013-01-23 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2013-01-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2012-07-25 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2009-04-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CAMBRIA CAPITAL, LLC